K/BxN Serum-Transfer Arthritis as a Model for Human Inflammatory Arthritis

Kouskoff, 1996, Organ-specific disease provoked by systemic autoimmunity, Cell, 87, 811, 10.1016/S0092-8674(00)81989-3

Matsumoto, 1999, Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme, Science, 286, 1732, 10.1126/science.286.5445.1732

Ditzel, 2004, The K/BxN mouse: a model of human inflammatory arthritis, Trends Mol Med, 10, 40, 10.1016/j.molmed.2003.11.004

Korganow, 1999, From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins, Immunity, 10, 451, 10.1016/S1074-7613(00)80045-X

Mangialaio, 1999, The arthritogenic T cell receptor and its ligand in a model of spontaneous arthritis, Arthritis Rheum, 42, 2517, 10.1002/1529-0131(199912)42:122517::AID-ANR33.0.CO;2-W

Ji, 2001, Genetic influences on the end-stage effector phase of arthritis, J Exp Med, 194, 321, 10.1084/jem.194.3.321

Choi, 2012, The pathogenesis of systemic lupus erythematosus – an update, Curr Opin Immunol, 24, 651, 10.1016/j.coi.2012.10.004

Wright, 2012, Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays, Mol Cell Proteomics, 11, M9.00384, 10.1074/mcp.M9.00384

Matsumoto, 2002, How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease, Nat Immunol, 3, 360, 10.1038/ni772

Wipke, 2002, Dynamic visualization of a joint-specific autoimmune response through positron emission tomography, Nat Immunol, 3, 366, 10.1038/ni775

Maccioni, 2002, Arthritogenic monoclonal antibodies from K/BxN mice, J Exp Med, 195, 1071, 10.1084/jem.20011941

Wipke, 2004, Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes, J Immunol, 172, 7694, 10.4049/jimmunol.172.12.7694

Corr, 2002, The role of FcyR signaling in the K/BxN serum transfer model of arthritis, J Immunol, 169, 6604, 10.4049/jimmunol.169.11.6604

Binstadt, 2006, Particularities of the vasculature can promote the organ specificity of autoimmune attack, Nat Immunol, 7, 284, 10.1038/ni1306

Nimmerjahn, 2007, Fc-receptors as regulators of immunity, Adv Immunol, 96, 179, 10.1016/S0065-2776(07)96005-8

Ji, 2002, Arthritis critically dependent on innate immune system players, Immunity, 16, 157, 10.1016/S1074-7613(02)00275-3

Boross, 2008, Destructive arthritis in the absence of both FcyRI and FcyRIII, J Immunol, 180, 5083, 10.4049/jimmunol.180.7.5083

Mancardi, 2011, Cutting edge: the murine high-affinity IgG receptor FcyRIV is sufficient for autoantibody-induced arthritis, J Immunol, 186, 1899, 10.4049/jimmunol.1003642

Seeling, 2013, Inflammatory monocytes and Fcgamma receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice, Proc Natl Acad Sci U S A, 110, 10729, 10.1073/pnas.1301001110

Bruhns, 2003, Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease, Immunity, 18, 573, 10.1016/S1074-7613(03)00080-3

Campbell, 2014, Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils, J Immunol, 192, 5031, 10.4049/jimmunol.1301611

Fiebiger, 2015, Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs, Proc Natl Acad Sci U S A, 112, E2385, 10.1073/pnas.1505292112

Anthony, 2011, Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway, Nature, 475, 110, 10.1038/nature10134

Samuelsson, 2001, Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor, Science, 291, 484, 10.1126/science.291.5503.484

Wipke, 2001, Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis, J Immunol, 167, 1601, 10.4049/jimmunol.167.3.1601

Daley, 2008, Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice, J Leukoc Biol, 83, 64, 10.1189/jlb.0407247

Wang, 2012, Ly6G ligation blocks recruitment of neutrophils via a beta2-integrin-dependent mechanism, Blood, 120, 1489, 10.1182/blood-2012-01-404046

Monach, 2010, Neutrophils in a mouse model of autoantibody-mediated arthritis: critical producers of Fc receptor gamma, the receptor for C5a, and lymphocyte function-associated antigen 1, Arthritis Rheum, 62, 753, 10.1002/art.27238

Tager, 2000, BLTR mediates leukotriene B(4)-induced chemotaxis and adhesion and plays a dominant role in eosinophil accumulation in a murine model of peritonitis, J Exp Med, 192, 439, 10.1084/jem.192.3.439

Haribabu, 2000, Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis, J Exp Med, 192, 433, 10.1084/jem.192.3.433

Chen, 2006, Neutrophil-derived leukotriene B4 is required for inflammatory arthritis, J Exp Med, 203, 837, 10.1084/jem.20052371

Kim, 2006, A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis, J Exp Med, 203, 829, 10.1084/jem.20052349

Chou, 2010, Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis, Immunity, 33, 266, 10.1016/j.immuni.2010.07.018

Jacobs, 2010, Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model, Arthritis Rheum, 62, 1921, 10.1002/art.27470

Sadik, 2012, Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and FcgammaR signaling, Proc Natl Acad Sci U S A, 109, E3177, 10.1073/pnas.1213797109

Shushakova, 2002, C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease, J Clin Invest, 110, 1823, 10.1172/JCI16577

Jakus, 2010, Genetic deficiency of Syk protects mice from autoantibody-induced arthritis, Arthritis Rheum, 62, 1899, 10.1002/art.27438

Elliott, 2011, Deletion of Syk in neutrophils prevents immune complex arthritis, J Immunol, 187, 4319, 10.4049/jimmunol.1100341

Christensen, 2016, Granulocyte colony-stimulating factor (G-CSF) plays an important role in immune complex-mediated arthritis, Eur J Immunol, 46, 1235, 10.1002/eji.201546185

Blom, 2000, Fc gamma R expression on macrophages is related to severity and chronicity of synovial inflammation and cartilage destruction during experimental immune-complex-mediated arthritis (ICA), Arthritis Res, 2, 489, 10.1186/ar131

Solomon, 2005, A crucial role for macrophages in the pathology of K/BxN serum-induced arthritis, Eur J Immunol, 35, 3064, 10.1002/eji.200526167

Misharin, 2014, Nonclassical Ly6C(-) monocytes drive the development of inflammatory arthritis in mice, Cell Rep, 9, 591, 10.1016/j.celrep.2014.09.032

Cook, 2011, Regulation of systemic and local myeloid cell subpopulations by bone marrow cell-derived granulocyte-macrophage colony-stimulating factor in experimental inflammatory arthritis, Arthritis Rheum, 63, 2340, 10.1002/art.30354

Hamilton, 2015, GM-CSF as a target in inflammatory/autoimmune disease: current evidence and future therapeutic potential, Expert Rev Clin Immunol, 11, 457, 10.1586/1744666X.2015.1024110

Feyerabend, 2011, Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity, Immunity, 35, 832, 10.1016/j.immuni.2011.09.015

Lee, 2002, Mast cells: a cellular link between autoantibodies and inflammatory arthritis, Science, 297, 1689, 10.1126/science.1073176

Nigrovic, 2007, Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1, Proc Natl Acad Sci U S A, 104, 2325, 10.1073/pnas.0610852103

Kneilling, 2007, Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice, Arthritis Rheum, 56, 1806, 10.1002/art.22602

Shin, 2009, Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes, J Immunol, 182, 647, 10.4049/jimmunol.182.1.647

Kim, 2006, FcyRIII engagement provides activating signals to NKT cells in antibody-induced joint inflammation, J Clin Invest, 116, 2484, 10.1172/JCI27219

Kim, 2005, NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor B1 production, J Exp Med, 201, 41, 10.1084/jem.20041400

Solomon, 2002, Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptors 1 and 2 (CD21/35), Eur J Immunol, 32, 644, 10.1002/1521-4141(200203)32:3644::AID-IMMU6443.0.CO;2-5

Monach, 2007, Circulating C3 is necessary and sufficient for induction of autoantibody-mediated arthritis in a mouse model, Arthritis Rheum, 56, 2968, 10.1002/art.22859

Klaus, 1979, Activation of mouse complement by different classes of mouse antibody, Immunology, 38, 687

McInnes, 2011, The pathogenesis of rheumatoid arthritis, N Engl J Med, 365, 2205, 10.1056/NEJMra1004965

van den Berg, 2009, Lessons from animal models of arthritis over the past decade, Arthritis Res Ther, 11, 250, 10.1186/ar2803

Ji, 2002, Critical roles for interleukin 1 and tumor necrosis factor a in antibody-induced arthritis, J Exp Med, 196, 77, 10.1084/jem.20020439

Kyburz, 2000, The role of CD40 ligand and tumor necrosis factor a signaling in the transgenic K/BxN mouse model of rheumatoid arthritis, Arthritis Rheum, 43, 2571, 10.1002/1529-0131(200011)43:112571::AID-ANR263.0.CO;2-4

Lamacchia, 2012, Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice, Ann Rheum Dis, 71, 281, 10.1136/annrheumdis-2011-200429

Ouyang, 2008, The biological functions of T helper 17 cell effector cytokines in inflammation, Immunity, 28, 454, 10.1016/j.immuni.2008.03.004

Patel, 2013, Effect of IL-17A blockade with secukinumab in autoimmune diseases, Ann Rheum Dis, 72, ii116, 10.1136/annrheumdis-2012-202371

Jacobs, 2009, IL-17-producing T cells can augment autoantibody-induced arthritis, Proc Natl Acad Sci U S A, 106, 21789, 10.1073/pnas.0912152106

Katayama, 2013, Neutrophils are essential as a source of IL-17 in the effector phase of arthritis, PLoS One, 8, e62231, 10.1371/journal.pone.0062231

Koenders, 2006, Interleukin-17 acts independently of TNF-alpha under arthritic conditions, J Immunol, 176, 6262, 10.4049/jimmunol.176.10.6262

Chen, 2008, Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody-driven K/BxN serum-transfer arthritis, Arthritis Rheum, 58, 1354, 10.1002/art.23453

Koenders, 2015, Novel therapeutic targets in rheumatoid arthritis, Trends Pharmacol Sci, 36, 189, 10.1016/j.tips.2015.02.001

Brightbill, 1999, Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors, Science, 285, 732, 10.1126/science.285.5428.732

Adachi, 1998, Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function, Immunity, 9, 143, 10.1016/S1074-7613(00)80596-8

Choe, 2003, Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling, J Exp Med, 197, 537, 10.1084/jem.20021850

Christianson, 2011, Spinal TLR4 mediates the transition to a persistent mechanical hypersensitivity after the resolution of inflammation in serum-transferred arthritis, Pain, 152, 2881, 10.1016/j.pain.2011.09.020

Abdollahi-Roodsaz, 2013, Toll-like receptor 2 controls acute immune complex-driven arthritis in mice by regulating the inhibitory Fcgamma receptor IIB, Arthritis Rheum, 65, 2583, 10.1002/art.38087

Kim, 2012, TLR4-mediated IL-12 production enhances IFN-gamma and IL-1beta production, which inhibits TGF-beta production and promotes antibody-induced joint inflammation, Arthritis Res Ther, 14, R210, 10.1186/ar4048

Wu, 2007, Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk, J Exp Med, 204, 1911, 10.1084/jem.20070285

Duffau, 2015, Promotion of inflammatory arthritis by interferon regulatory factor 5 in a mouse model, Arthritis Rheumatol, 67, 3146, 10.1002/art.39321

Hogg, 2003, T-cell integrins: more than just sticking points, J Cell Sci, 116, 4695, 10.1242/jcs.00876

Ueda, 1994, Identification of the complement iC3b binding site in the beta 2 integrin CR3 (CD11b/CD18), Proc Natl Acad Sci U S A, 91, 10680, 10.1073/pnas.91.22.10680

Watts, 2005, Manifestations of inflammatory arthritis are critically dependent on LFA-1, J Immunolog, 174, 3668, 10.4049/jimmunol.174.6.3668

Henderson, 2003, Rapid recruitment of inflammatory monocytes is independent of neutrophil migration, Blood, 102, 328, 10.1182/blood-2002-10-3228

Garcia, 2010, Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K/BxN serum-transfer arthritis model, Arthritis Res Ther, 12, R224, 10.1186/ar3211

Joosten, 1999, IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation, J Immunol, 163, 5049, 10.4049/jimmunol.163.9.5049

Pettit, 2001, TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis, Am J Pathol, 159, 1689, 10.1016/S0002-9440(10)63016-7

Chen, 2014, MIF, a potential therapeutic target for rheumatoid arthritis?, Rheumatol Int, 34, 1481, 10.1007/s00296-013-2877-y

Singh, 2013, Macrophage-derived, macrophage migration inhibitory factor (MIF) is necessary to induce disease in the K/BxN serum-induced model of arthritis, Rheumatol Int, 33, 2301, 10.1007/s00296-013-2713-4

Gu, 2015, Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis, Cytokine, 72, 135, 10.1016/j.cyto.2014.11.015

Walsh, 2014, Mechanisms, impact and management of pain in rheumatoid arthritis, Nat Rev Rheumatol, 10, 581, 10.1038/nrrheum.2014.64

Christianson, 2010, Characterization of the acute and persistent pain state present in K/BxN serum transfer arthritis, Pain, 151, 394, 10.1016/j.pain.2010.07.030

Christianson, 2012, K/BxN serum transfer arthritis as a model of inflammatory joint pain, Methods Mol Biol, 851, 249, 10.1007/978-1-61779-561-9_19

Borbely, 2015, Capsaicin-sensitive sensory nerves exert complex regulatory functions in the serum-transfer mouse model of autoimmune arthritis, Brain Behav Immunol, 45, 50, 10.1016/j.bbi.2014.12.012

Rao, 2012, The neuropeptide neuromedin U promotes autoantibody-mediated arthritis, Arthritis Res Ther, 14, R29, 10.1186/ar3732

Stangenberg, 2014, Denervation protects limbs from inflammatory arthritis via an impact on the microvasculature, Proc Natl Acad Sci U S A, 111, 11419, 10.1073/pnas.1410854111

Nandakumar, 2006, Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis, Arthritis Res Ther, 8, 223, 10.1186/ar2089

Kagari, 2002, The importance of IL-1-beta and TNF-alpha, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis, J Immunol, 169, 1459, 10.4049/jimmunol.169.3.1459

Nandakumar, 2004, Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells, Arthritis Res Ther, 6, R544, 10.1186/ar1217

Kagari, 2003, Essential role of Fcy receptors in anti-type II collagen antibody-induced arthritis, J Immunol, 170, 4318, 10.4049/jimmunol.170.8.4318

Banda, 2012, Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice, J Immunol, 188, 1469, 10.4049/jimmunol.1102310

Tanaka, 2006, Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis, Immunology, 119, 195, 10.1111/j.1365-2567.2006.02424.x

Banda, 2006, Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis, J Immunol, 177, 1904, 10.4049/jimmunol.177.3.1904

Hietala, 2004, Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis, Eur J Immunol, 34, 1208, 10.1002/eji.200424895

Banda, 2007, Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway, J Immunol, 179, 4101, 10.4049/jimmunol.179.6.4101

Khachigian, 2006, Collagen antibody-induced arthritis, Nat Protocols, 1, 2512, 10.1038/nprot.2006.393

Rosloniec, 2010, Collagen-induced arthritis, Curr Protoc Immunol, 10.1002/0471142735.im1505s89

Monach, 2008, The K/BxN arthritis model, Curr Protoc Immunol, 10.1002/0471142735.im1522s81

Kannan, 2005, Animal models of rheumatoid arthritis and their relevance to human disease, Pathophysiology, 12, 167, 10.1016/j.pathophys.2005.07.011

Watson, 1985, Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci, J Exp Med, 162, 1878, 10.1084/jem.162.6.1878

Kleinau, 2000, Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors, J Exp Med, 191, 1611, 10.1084/jem.191.9.1611

Ståhl, 2002, Expression of FcγRIII is required for development of collagen-induced arthritis, Eur J Immunol, 32, 2915, 10.1002/1521-4141(2002010)32:102915:AID-IMMU29153.0.CO;2-4

Andersson, 2014, Rapid-onset clinical and mechanistic effects of anti-C5aR treatment in the mouse collagen-induced arthritis model, Clin Exp Immunol, 177, 219, 10.1111/cei.12338

Hietala, 2002, Complement deficiency ameliorates collagen-induced arthritis in mice, J Immunol, 169, 454, 10.4049/jimmunol.169.1.454

Eyles, 2008, A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis, Blood, 112, 5193, 10.1182/blood-2008-02-139535

Van Lent, 1998, Local removal of phagocytic synovial lining cells by clodronate-liposomes decreases cartilage destruction during collagen type II arthritis, Ann Rheum Dis, 57, 408, 10.1136/ard.57.7.408

Nandakumar, 2006, Arthritis induced with cartilage-specific antibodies is IL-4-dependent, Eur J Immunol, 36, 1608, 10.1002/eji.200535633

Campbell, 1998, Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice, J Immunol, 161, 3639, 10.4049/jimmunol.161.7.3639

Fujimoto, 2008, Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses, Arthritis Rheum, 58, 3710, 10.1002/art.24126

Lubberts, 2001, IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis, J Immunol, 167, 1004, 10.4049/jimmunol.167.2.1004

Ohmura, 2005, Interleukin-4 can be a key positive regulator of inflammatory arthritis, Arthritis Rheum, 52, 1866, 10.1002/art.21104

Holmdahl, 1991, Multiple epitopes on cartilage type II collagen are accessible for antibody binding in vivo, Autoimmunity, 10, 27, 10.3109/08916939108997144

Crombie, 2005, Destructive effects of murine arthritogenic antibodies to type II collagen on cartilage explants in vitro, Arthritis Res Ther, 7, R927, 10.1186/ar1766

Hegen, 2008, Utility of animal models for identification of potential therapeutics for rheumatoid arthritis, Ann Rheum Dis, 67, 1505, 10.1136/ard.2007.076430

Asquith, 2009, Animal models of rheumatoid arthritis, Eur J Immunol, 39, 2040, 10.1002/eji.200939578

Horsfall, 1997, Suppression of collagen-induced arthritis by continuous administration of IL-4, J Immunol, 159, 5687, 10.4049/jimmunol.159.11.5687

Yazici, 2000, Elderly-onset rheumatoid arthritis, Rheum Dis Clin North Am, 26, 517, 10.1016/S0889-857X(05)70154-X

Firestein, 2003, Evolving concepts of rheumatoid arthritis, Nature, 423, 356, 10.1038/nature01661

van Boekel, 2002, Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value, Arthritis Res, 4, 87, 10.1186/ar533

Berglin, 2004, A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis, Arthritis Res Ther, 6, R303, 10.1186/ar1187

Ytterberg, 2012, Ways forward to identify new ACPA targets in RA, Arthritis Res Ther, 14, 124, 10.1186/ar4031

Monach, 2004, The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease, Adv Immunol, 82, 217, 10.1016/S0065-2776(04)82005-4

Firestein, 2005, Immunologic mechanisms in the pathogenesis of rheumatoid arthritis, J Clin Rheumatol, 11, S39, 10.1097/01.rhu.0000166673.34461.33

Patel, 2012, The impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis, Ann Rheum Dis, 71, 1872, 10.1136/annrheumdis-2011-201180

Ryan, 2013, An intra-articular salmon calcitonin-based nanocomplex reduces experimental inflammatory arthritis, J Control Release, 167, 120, 10.1016/j.jconrel.2013.01.027

Zhou, 2010, Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis, Nanomedicine (Lond), 5, 1065, 10.2217/nnm.10.78

Choe, 2013, Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes, Arthritis Res Ther, 15, R26, 10.1186/ar4162

Schaller, 2001, Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease, Nat Immunol, 2, 746, 10.1038/90696

Matsumoto, 2003, Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders, Arthritis Rheum, 48, 944, 10.1002/art.10898

Schubert, 2002, Autoantibodies to GPI and creatine kinase in RA, Nat Immunol, 3, 411, 10.1038/ni0502-411a

Kassahn, 2002, Few human autoimmune sera detect GPI, Nat Immunol, 3, 411, 10.1038/ni0502-411b

Herve, 2003, Glucose-6-phosphate isomerase is not a specific autoantigen in rheumatoid arthritis, Rheumatology (Oxford), 42, 986, 10.1093/rheumatology/keg271

van Gaalen, 2004, Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritis, Arthritis Rheum, 50, 395, 10.1002/art.20028

Schaller, 2005, Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis, Ann Rheum Dis, 64, 743, 10.1136/ard.2004.025502

Zong, 2015, Glucose-6-phosphate isomerase promotes the proliferation and inhibits the apoptosis in fibroblast-like synoviocytes in rheumatoid arthritis, Arthritis Res Ther, 17, 100, 10.1186/s13075-015-0619-0

van den Berg, 2001, Anti-cytokine therapy in chronic destructive arthritis, Arthritis Res, 3, 18, 10.1186/ar303

Kollias, 2011, Animal models for arthritis: innovative tools for prevention and treatment, Ann Rheum Dis, 70, 1357, 10.1136/ard.2010.148551

Vincent, 2012, Arthritis Research UKamwg. Mapping pathogenesis of arthritis through small animal models, Rheumatology (Oxford), 51, 1931, 10.1093/rheumatology/kes035